YD Bio YDES
NASDAQ YDES
$6.19 -0.99 (-13.79%)
At close: Nov 6, 2026 · 4:00 PM EST

YD Bio (YDES) Total Non-Current Liabilities (2024 - 2026)

Updated

YD Bio (YDES) posted Total Non-Current Liabilities of $1.07 million for the quarter ended Jun 30, 2026, up 55.1% from $689,192 a year earlier.

Analysis

YD Bio (YDES) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, YD Bio's Total Non-Current Liabilities came in at $1.64 million, up 594.3% from the prior year.

  • In prior years, YD Bio's Total Non-Current Liabilities was $236,727 in the year ended Dec 31, 2024.
  • Quarterly Total Non-Current Liabilities has run from a low of $236,727 in the quarter ended Dec 31, 2024 to a high of $1.64 million in the quarter ended Dec 31, 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 102.65 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 117.60 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -36.84 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 96.04 Bn
10 YD Bio 397.65 Mn 385.37 Mn - 1.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.07 Mn
Dec 31, 2025 1.64 Mn
Dec 31, 2024 270,207.00
API Access

YD Bio Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=YDES&period=max&api_key=YOUR_API_KEY